New Products

SAN DIEGO — Cardium Therapeutics earlier this week announced its To Go Brands operating unit has expanded its VitaRocks kids' vitamins product line and that retail distribution has been expanded into select Target stores.

The VitaRocks products are inspired by a popping pellet candy that is popular with kids and represents a next-generation, easy-use delivery platform for multivitamins and nutrients, dietary supplements, and potentially over-the-counter medicines for children as well as adults, Cardium Therapeutics suggested. 

GREENWICH, Conn. — B’iota Botanicals, a European brand in herbal hair and skin care solutions, is now available in the United States.

The core products for the U.S. launch are B’iota shampoos and [leave-in] serum, which have been clinically tested and shown to reduce hair fallout and thinning by promoting stronger, thicker, fuller hair, the company stated. The products are targeted to women and men who have weak, damaged and thinning hair.

MINONG, Wis. — Jack Link's meat snack brand has introduced a new line of turkey snacks, the company recently announced.

The new portfolio of turkey snacks includes five new offerings from the company:

BEDMINSTER, N.J. — The Food and Drug Administration will decide in late August whether to approve an experimental opioid painkiller made by QRxPharma, the drug maker said Thursday.

Australia-based QRxPharma is seeking approval for Moxduo (morphine and oxycodone), and the FDA plans to decide whether to approve the drug on Aug. 26.

FAIRFIELD, Calif. — Jelly Belly Candy Company has introduced new Jelly Belly Tabasco jelly bean bottles to candy shelves, the company announced today.

Jelly Belly Tabasco jelly beans mimic the traditional Tabasco brand bottle and are filled with the newest Jelly Belly jelly beans spiced with genuine Tabasco brand seasonings.

WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a drug for obsessive compulsive disorder made by Par Pharmaceutical Cos., the drug maker said Thursday.

Par announced the approval and shipment of fluvoxamine maleate extended-release capsules in the 100-mg and 150-mg strengths. The drug is a generic version of Jazz Pharmaceuticals' Luvox CR.

PITTSBURGH — Mylan has settled a patent-infringement lawsuit filed by Shionogi over its generic version of a drug for diabetes, Mylan said.

The generic drug maker said that under the agreement, it can launch a generic version of Shionogi's Fortamet (metformin hydrochloride) extended-release tablets in the 500-mg and 1,000-mg strengths on Aug. 1.

Metformin hydrochloride extended-release tablets in those two strengths had sales of about $125 million during the 12-month period that ended in September, according to IMS Health.

ATLANTA — SoloHealth on Thursday announced it has been selected as one of the Technology Association of Georgia’s Top 10 Innovative Technology Companies. SoloHealth was recognized for its FDA-approved health and wellness kiosk, the SoloHealth Station.

"The Top 10 awards are given to an elite group of companies whose products and solutions are not only changing their respective industries, they also are putting Georgia on the map as a state where technology innovation can thrive," stated Tino Mantella, president & CEO of TAG.